New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

FXHvsRSPHETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.1%
VS
ETF 2
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.1%

First Trust Health Care AlphaDEX Fund ETF (FXH) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. FXH's top 1 sector exposures are Healthcare. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.4% for RSPH. FXH is up 21.67% year-to-date (YTD) with +$33M in YTD flows. RSPH performs better with 26.32% YTD performance, and +$66M in YTD flows. Run a side-by-side ETF comparison of FXH and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs RSPH performance and flow charts

Performance

0246810%Oct 2Oct 9Oct 16Oct 23Oct 30

Cumulative Flows

-40 M-20 M0 M20 M40 MOct 2Oct 9Oct 16Oct 23Oct 30

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/02/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
RSPH
+6.30%+7.38%
+7.90%+14.07%
+21.67%+26.32%
+24.45%+33.11%
+52.31%+54.19%
+15.44%+33.18%
Flows
FXH
RSPH
-$39M+$38M
+$20M+$109M
+$33M+$66M
+$39M+$64M
-$445M-$215M
-$464M-$191M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
RSPH
+14.89%+18.14%
+15.68%+16.85%
+15.66%+15.88%
+16.95%+16.81%
Max drawdown
FXH
RSPH
-4.82%-5.57%
-12.07%-10.87%
-17.66%-16.96%
-27.47%-21.91%
Max drawdown duration
FXH
RSPH
55d55d
168d116d
395d434d
1638d817d
Trading data

Create an account to view trading data

Join for free
FXH
RSPH
Last sale
11/4/2026 at 2:30 PM
$143.71
$41.56
Previous close
11/03/2026
$137.97
$39.98
Consolidated volume
11/03/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/4/2026 at 2:30 PM
Live
Closed
FXH
RSPH
Last price
$143.71
$41.56
1D performance
+4.16%
+3.95%
AuM$1.16 B$996.11 M
E/R0.61%0.4%
Characteristics
FXH
RSPH
Management strategyPassivePassive
ProviderFirst TrustInvesco
BenchmarkStrataQuant Health Care IndexS&P 500 Equal Weight Health Care Index
N° of holdings7260
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007November 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
93.54%
Other
6.46%
RSPH
USA
96.84%
Other
3.16%

Sectors

FXH
Healthcare
98.5%
Other
1.5%
RSPH
Healthcare
98.51%
Other
1.49%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

35.85%
RSPH

Total weight of top 15 holdings out of 15

28.14%

Top 15 holdings

Data as of September 30, 2026
FXH
Natera, Inc.
3.34%
Universal Health Services, Inc.
2.62%
Regeneron Pharmaceuticals, Inc.
2.62%
Pfizer Inc.
2.60%
Guardant Health, Inc.
2.59%
Solventum Corp.
2.53%
Zimmer Biomet Holdings, Inc.
2.27%
Halozyme Therapeutics, Inc.
2.27%
Tenet Healthcare Corp.
2.25%
Boston Scientific Corp.
2.25%
Corcept Therapeutics, Inc.
2.18%
The Cigna Group
2.16%
Centene Corp.
2.11%
Globus Medical, Inc.
2.09%
Medline, Inc.
1.97%
RSPH
Moderna, Inc.
2.35%
Illumina, Inc.
2.14%
Revvity, Inc.
1.97%
Agilent Technologies, Inc.
1.96%
Mettler-Toledo International, Inc.
1.94%
Intuitive Surgical, Inc.
1.90%
Thermo Fisher Scientific, Inc.
1.81%
West Pharmaceutical Services, Inc.
1.80%
Danaher Corp.
1.79%
Viatris, Inc.
1.79%
Waters Corp.
1.77%
Biogen, Inc.
1.75%
Veeva Systems, Inc.
1.74%
Amgen, Inc.
1.73%
AbbVie, Inc.
1.71%
Frequently asked questions about FXH and RSPH

How have the FXH and RSPH ETFs performed in 2026?

As of November 2, 2026, FXH is up 21.67% year-to-date (YTD), while RSPH has returned 26.32%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or RSPH?

Year-to-date, the FXH ETF saw +$33M in flows, compared to +$66M for RSPH.

Which ETF is more volatile: FXH or RSPH?

Over the past year, FXH had a volatility of 15.68%, while RSPH experienced 16.85%.

Which ETF is bigger: FXH or RSPH?

As of November 2, 2026, FXH holds $1.16 B in assets under management (AUM), while RSPH manages $996.11 M.

What sectors do the FXH and RSPH ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the FXH ETF and RSPH ETF?

FXH top holdings include Natera, Inc., Universal Health Services, Inc. and Regeneron Pharmaceuticals, Inc.. RSPH holds in its top three: Moderna, Inc., Illumina, Inc. and Revvity, Inc..

Which ETF is more diversified: FXH or RSPH?

FXH holds 72 securities with 35.85% of its assets in the top 15. RSPH has 60 securities and a top 15 weight of 28.14%.

Advertisement
Latest news about FXH & RSPH
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026